Thu. 7 Mar 2024, 4:03pm ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.320) per share which beat the analyst consensus estimate of $(0.760) by 57.89 percent. The company reported quarterly sales of $33.989 million which missed the analyst consensus estimate of $37.856 million by 10.22 percent. This is a 78.80 percent decrease over sales of $160.293 million the same period last year.